EnBiotix

Cambridge, United States

EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.

$3.5M raised

Apr 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EnBiotix raised?

EnBiotix has raised $3.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2022.

Who are EnBiotix's investors?

EnBiotix's investors include Cystic Fibrosis Foundation, Apeiron Holdings Limited, Vectura, Sanford Biosciences, Wired Holdings.

Where is EnBiotix headquartered?

EnBiotix is headquartered in Cambridge, United States.

What does EnBiotix do?

EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.

What stage is EnBiotix at?

EnBiotix is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 5, 2022.

MLA

"EnBiotix — Funding & Investors." VCBacked, April 5, 2022, https://www.vcbacked.co/company/enbiotix. Accessed July 3, 2026.

APA

VCBacked. (2022). EnBiotix — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/enbiotix

Wikipedia (cite web)

{{cite web |title=EnBiotix — Funding & Investors |url=https://www.vcbacked.co/company/enbiotix |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 5, 2022.